Close Menu

NEW YORK – Immunovia is making progress in moving tests for two different indications closer to clinical use.

The Swedish molecular diagnostics company recently announced a partnership with investigators at Leiden University Medical Center in the Netherlands to study the use of its Immray platform to diagnose patients with rheumatoid arthritis (RA). Separately, the company announced progress in a partnership with a pharmaceutical partner related to lung cancer.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.